Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy

Francesca Cesari, Rossella Marcucci, Roberto Caporale, Rita Paniccia, Eloisa Romano, Gian Franco Gensini, Rosanna Abbate, Anna Maria Gori

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

A high platelet turnover rate produce a population of immature reticulated platelets (RP) that could confer, despite of antiplatelet drugs, a residual platelet reactivity (RPR) in coronary artery disease (CAD) patients. To assess the influence of RP on platelet reactivity in CAD patients on dual antiplatelet therapy we measured RP in 372 patients by using the Sysmex XE-2100 haematology analyzer and platelet function by optical platelet aggregometry (PA) on platelet-rich-plasma induced by 1 mmol arachidonic acid (AA-PA) and 10 μM ADP (ADP-PA). RPR was defined as either AA-PA >20% or ADP-PA >70%. RP were expressed as a percentage of RP of the total optical platelet count (immature platelet fraction; IPF) and as the percentage of RP highly fluorescent (higly fluorescent immature platelet fraction; H-IPF). Moderate but significant positive correlations between PA, IPF, H-IPF, and mean platelet volume (MPV) were found. According to tertiles of IPF, H-IPF and MPV, a significant trend for an increase of platelet aggregation by AA and ADP was evidenced. Furthermore, a significant difference for IPF, H-IPF and MPV between patients with and without RPR was observed. A linear regression analysis showed that IPF, H-IPF and MPV significantly affected PA measured by AA and ADP. At multivariate linear regression analysis these associations were confirmed. Moreover, a logistic regression analysis demonstrated that IPF, H-IPF and MPV significantly influenced the risk of RPR, and in the multivariate model these results remained significant. This study indicates that a high rate of platelet turnover is a new mechanism associated with platelet reactivity in high risk CAD patients on dual antiplatelet therapy.

Original languageEnglish
Pages (from-to)930-935
Number of pages6
JournalThrombosis and Haemostasis
Volume99
Issue number5
DOIs
Publication statusPublished - May 2008

Fingerprint

Coronary Artery Disease
Blood Platelets
Mean Platelet Volume
Therapeutics
Adenosine Diphosphate
Regression Analysis
Linear Models
Platelet-Rich Plasma
Platelet Aggregation Inhibitors
Hematology

Keywords

  • Antiplatelet therapy
  • CAD patients
  • Platelet reactivity
  • Platelet turnover
  • Reticulated platelets

ASJC Scopus subject areas

  • Hematology

Cite this

Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. / Cesari, Francesca; Marcucci, Rossella; Caporale, Roberto; Paniccia, Rita; Romano, Eloisa; Gensini, Gian Franco; Abbate, Rosanna; Gori, Anna Maria.

In: Thrombosis and Haemostasis, Vol. 99, No. 5, 05.2008, p. 930-935.

Research output: Contribution to journalArticle

Cesari, Francesca ; Marcucci, Rossella ; Caporale, Roberto ; Paniccia, Rita ; Romano, Eloisa ; Gensini, Gian Franco ; Abbate, Rosanna ; Gori, Anna Maria. / Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. In: Thrombosis and Haemostasis. 2008 ; Vol. 99, No. 5. pp. 930-935.
@article{220d8e23a21e4f3685cb2015fd4221fd,
title = "Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy",
abstract = "A high platelet turnover rate produce a population of immature reticulated platelets (RP) that could confer, despite of antiplatelet drugs, a residual platelet reactivity (RPR) in coronary artery disease (CAD) patients. To assess the influence of RP on platelet reactivity in CAD patients on dual antiplatelet therapy we measured RP in 372 patients by using the Sysmex XE-2100 haematology analyzer and platelet function by optical platelet aggregometry (PA) on platelet-rich-plasma induced by 1 mmol arachidonic acid (AA-PA) and 10 μM ADP (ADP-PA). RPR was defined as either AA-PA >20{\%} or ADP-PA >70{\%}. RP were expressed as a percentage of RP of the total optical platelet count (immature platelet fraction; IPF) and as the percentage of RP highly fluorescent (higly fluorescent immature platelet fraction; H-IPF). Moderate but significant positive correlations between PA, IPF, H-IPF, and mean platelet volume (MPV) were found. According to tertiles of IPF, H-IPF and MPV, a significant trend for an increase of platelet aggregation by AA and ADP was evidenced. Furthermore, a significant difference for IPF, H-IPF and MPV between patients with and without RPR was observed. A linear regression analysis showed that IPF, H-IPF and MPV significantly affected PA measured by AA and ADP. At multivariate linear regression analysis these associations were confirmed. Moreover, a logistic regression analysis demonstrated that IPF, H-IPF and MPV significantly influenced the risk of RPR, and in the multivariate model these results remained significant. This study indicates that a high rate of platelet turnover is a new mechanism associated with platelet reactivity in high risk CAD patients on dual antiplatelet therapy.",
keywords = "Antiplatelet therapy, CAD patients, Platelet reactivity, Platelet turnover, Reticulated platelets",
author = "Francesca Cesari and Rossella Marcucci and Roberto Caporale and Rita Paniccia and Eloisa Romano and Gensini, {Gian Franco} and Rosanna Abbate and Gori, {Anna Maria}",
year = "2008",
month = "5",
doi = "10.1160/TH08-01-0002",
language = "English",
volume = "99",
pages = "930--935",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "5",

}

TY - JOUR

T1 - Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy

AU - Cesari, Francesca

AU - Marcucci, Rossella

AU - Caporale, Roberto

AU - Paniccia, Rita

AU - Romano, Eloisa

AU - Gensini, Gian Franco

AU - Abbate, Rosanna

AU - Gori, Anna Maria

PY - 2008/5

Y1 - 2008/5

N2 - A high platelet turnover rate produce a population of immature reticulated platelets (RP) that could confer, despite of antiplatelet drugs, a residual platelet reactivity (RPR) in coronary artery disease (CAD) patients. To assess the influence of RP on platelet reactivity in CAD patients on dual antiplatelet therapy we measured RP in 372 patients by using the Sysmex XE-2100 haematology analyzer and platelet function by optical platelet aggregometry (PA) on platelet-rich-plasma induced by 1 mmol arachidonic acid (AA-PA) and 10 μM ADP (ADP-PA). RPR was defined as either AA-PA >20% or ADP-PA >70%. RP were expressed as a percentage of RP of the total optical platelet count (immature platelet fraction; IPF) and as the percentage of RP highly fluorescent (higly fluorescent immature platelet fraction; H-IPF). Moderate but significant positive correlations between PA, IPF, H-IPF, and mean platelet volume (MPV) were found. According to tertiles of IPF, H-IPF and MPV, a significant trend for an increase of platelet aggregation by AA and ADP was evidenced. Furthermore, a significant difference for IPF, H-IPF and MPV between patients with and without RPR was observed. A linear regression analysis showed that IPF, H-IPF and MPV significantly affected PA measured by AA and ADP. At multivariate linear regression analysis these associations were confirmed. Moreover, a logistic regression analysis demonstrated that IPF, H-IPF and MPV significantly influenced the risk of RPR, and in the multivariate model these results remained significant. This study indicates that a high rate of platelet turnover is a new mechanism associated with platelet reactivity in high risk CAD patients on dual antiplatelet therapy.

AB - A high platelet turnover rate produce a population of immature reticulated platelets (RP) that could confer, despite of antiplatelet drugs, a residual platelet reactivity (RPR) in coronary artery disease (CAD) patients. To assess the influence of RP on platelet reactivity in CAD patients on dual antiplatelet therapy we measured RP in 372 patients by using the Sysmex XE-2100 haematology analyzer and platelet function by optical platelet aggregometry (PA) on platelet-rich-plasma induced by 1 mmol arachidonic acid (AA-PA) and 10 μM ADP (ADP-PA). RPR was defined as either AA-PA >20% or ADP-PA >70%. RP were expressed as a percentage of RP of the total optical platelet count (immature platelet fraction; IPF) and as the percentage of RP highly fluorescent (higly fluorescent immature platelet fraction; H-IPF). Moderate but significant positive correlations between PA, IPF, H-IPF, and mean platelet volume (MPV) were found. According to tertiles of IPF, H-IPF and MPV, a significant trend for an increase of platelet aggregation by AA and ADP was evidenced. Furthermore, a significant difference for IPF, H-IPF and MPV between patients with and without RPR was observed. A linear regression analysis showed that IPF, H-IPF and MPV significantly affected PA measured by AA and ADP. At multivariate linear regression analysis these associations were confirmed. Moreover, a logistic regression analysis demonstrated that IPF, H-IPF and MPV significantly influenced the risk of RPR, and in the multivariate model these results remained significant. This study indicates that a high rate of platelet turnover is a new mechanism associated with platelet reactivity in high risk CAD patients on dual antiplatelet therapy.

KW - Antiplatelet therapy

KW - CAD patients

KW - Platelet reactivity

KW - Platelet turnover

KW - Reticulated platelets

UR - http://www.scopus.com/inward/record.url?scp=43949115561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949115561&partnerID=8YFLogxK

U2 - 10.1160/TH08-01-0002

DO - 10.1160/TH08-01-0002

M3 - Article

C2 - 18449424

AN - SCOPUS:43949115561

VL - 99

SP - 930

EP - 935

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 5

ER -